Cover Image
市場調查報告書

小腸癌:全球臨床實驗檢討

Small Intestine Cancer Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 304742
出版日期 內容資訊 英文 116 Pages
訂單完成後即時交付
價格
Back to Top
小腸癌:全球臨床實驗檢討 Small Intestine Cancer Global Clinical Trials Review, H1, 2014
出版日期: 2014年05月26日 內容資訊: 英文 116 Pages
簡介

本報告提供小腸癌相關的臨床研究最新趨勢分析,提供疾病·治療方法概要,並彙整臨床實驗的主要國家,G7各國及E7(新興7國)的臨床實驗數及實驗對象採用狀況,地區、PHASE、階段別的進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

目錄

簡介

  • 小腸癌
  • 本報告概要

各地區的臨床實驗情形

各國臨床實驗數量和平均實驗人數

  • 亞太地區主要國家的臨床實驗數量
  • 歐洲前五名國家的臨床實驗數量
  • 北美主要國家的臨床實驗數量
  • 中東及非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:癌症臨床實驗數量中小腸癌的比率

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7(新興7個國家)的臨床實驗數量:癌症臨床實驗數量中小腸癌的比率

Phase別臨床實驗數量

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

試驗指標達成狀況別臨床實驗數量

尚未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • Vion Pharmaceuticals, Inc. (Inactive)
    • Silence Therapeutics AG
    • 大塚製藥
    • Oncothyreon Inc.
    • Novogen Limited
    • Novartis AG
    • F. Hoffmann-La Roche Ltd.
    • Eisai
    • Burzynski Research Institute, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Memorial Sloan Kettering Cancer Center
    • National Institutes of Health Clinical Center
    • North Central Cancer Treatment Group
    • Mayo Clinic
    • Ohio State University Comprehensive Cancer Center
    • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
    • University of Wisconsin Madison
    • Fox Chase Cancer Center
    • New York University School of Medicine

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2162CTIDB

GlobalData's clinical trial report, "Small Intestine Cancer Global Clinical Trials Review, H1, 2014" provides data on the Small Intestine Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Small Intestine Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Small Intestine Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Small Intestine Cancer
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
    • Top Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Small Intestine Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Small Intestine Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Small Intestine Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Small Intestine Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Vion Pharmaceuticals, Inc. (Inactive)
      • Clinical Trial Overview of Vion Pharmaceuticals, Inc. (Inactive)
      • Silence Therapeutics AG
      • Clinical Trial Overview of Silence Therapeutics AG
      • Otsuka Pharmaceutical Co., Ltd.
      • Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd.
      • Oncothyreon Inc.
      • Clinical Trial Overview of Oncothyreon Inc.
      • Novogen Limited
      • Clinical Trial Overview of Novogen Limited
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Eisai Inc.
      • Clinical Trial Overview of Eisai Inc.
      • Burzynski Research Institute, Inc.
      • Clinical Trial Overview of Burzynski Research Institute, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • National Institutes of Health Clinical Center
      • Clinical Trial Overview of National Institutes of Health Clinical Center
      • North Central Cancer Treatment Group
      • Clinical Trial Overview of North Central Cancer Treatment Group
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Ohio State University Comprehensive Cancer Center
      • Clinical Trial Overview of Ohio State University Comprehensive Cancer Center
      • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
      • Clinical Trial Overview of Robert H. Lurie Comprehensive Cancer Center of Northwestern University
      • University of Wisconsin Madison
      • Clinical Trial Overview of University of Wisconsin Madison
      • Fox Chase Cancer Center
      • Clinical Trial Overview of Fox Chase Cancer Center
      • New York University School of Medicine
      • Clinical Trial Overview of New York University School of Medicine
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Small Intestine Cancer Therapeutics, Global, Clinical Trials by Region, 2014*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Small Intestine Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Small Intestine Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Small Intestine Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Small Intestine Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Small Intestine Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Small Intestine Cancer Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Small Intestine Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vion Pharmaceuticals, Inc. (Inactive), 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Silence Therapeutics AG, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncothyreon Inc., 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novogen Limited, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Burzynski Research Institute, Inc., 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014*

List of Figures

  • Small Intestine Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Small Intestine Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Small Intestine Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Small Intestine Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Small Intestine Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Small Intestine Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Small Intestine Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Small Intestine Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top